// App-Quantinova.ai

1180-144 : SEVERE ANUERYSMAL DILATION OF ALL THREE CORONARY ARTERIES WITH EMBOLIZATION CAUSING STEMI: A MANAGEMENT DILEMMA

Researchers

Presenter

  • Christopher Rowan

Principal Investigators

  • N/A

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Coronary Artery Disease

  • Angina

  • Venous thrombosis

  • Kawasaki disease

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Clopidogrel bisulfate

  • Activase I.V.

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved